Trademarkia Logo

Canada

C$
Trademark Search in Canada
bora and Design

View On IC.GC.CA

bora and Design
APPROVED

on 3 Jun 2025

Last Applicant/ Owned by

BORA PHARMACEUTICALS CO. LTD.

6F., NO. 69, XING AI RDNEIHU DIST.TAIPEI CITY, 11494

TW

Serial Number

2059905 filed on 26th Oct 2020

Correspondent Address

FILLMORE RILEY LLP

1700 - 360 Main StreetWinnipeg

MANITOBA

CA

R3C3Z3

bora and Design

Trademark usage description

nutritional supplements for building body mass; nutritional supplements for general health and well-being; mineral nutritional supplements; antiallerg Read More

Vienna Information

24 . 17 . 5

Mathematical signsSignes mathématiques

24 . 17 . 7

Mathematical signs combined with figures or lettersSignes mathématiques combinés avec des chiffres ou des lettres

24 . 13 . 1

Greek cross, St. Andrew's crossCroix grecque ou de Saint-André

24 . 13 . 23

Crosses within a square or a rectangleCroix dans un carré ou un rectangle

26 . 4 . 1

SquaresCarrés

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 18

Quadrilaterals containing one or more lettersQuadrilatères contenant une ou plusieurs lettres

26 . 4 . 22

Quadrilaterals containing other inscriptionsQuadrilatères contenant d'autres inscriptions

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

Classification Information

Class [005]
Nutritional supplements for building body mass; nutritional supplements for general health and well-being; mineral nutritional supplements; Antiallergic medicines; Sulphonamides in the nature of medicines; intestinal disorder medicine for the treatment of intestinal bacteria and parasites; intestinal disorder medicine for the treatment of ulcerative colitis; Pharmaceutical preparations for the treatment of dental diseases; Medicines for alleviating constipation; Motion sickness medicines; Medicines for the treatment of gastrointestinal diseases; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Medicinal preparations for use in oncology; pharmaceutical preparations for use in ocular disorders; Antibiotic ointments; Antibiotic preparations; Mixed antibiotic preparations; Cardiovascular pharmaceutical preparations; Anti-diabetic pharmaceuticals; psychotropics; antihelmintics; anti-infectives; Pharmaceutical preparations for inducing erections; Injectable pharmaceuticals for treatment of anaphylactic reactions; Pharmaceuticals, namely, lipid lowering agents; Antimicrobial preparations for inhibiting microbiological decomposition; Pharmaceutical astringents; Pharmaceutical preparations for wounds; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; Calamine lotions; Medicated sunburn lotions; Medicated diaper rash lotions; Medicated after-shave lotions; Medicated topical tattoo skin lotions; antivirals; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for treating sunburn; Medicated skin care preparations for use as a skin cleanser; Medicated skin care preparations for use as a moisturizer; Anti-aging medicated skin care preparations; Medicated skin care preparations for treating, reducing, and preventing lines, pores, and loss of skin firmness; antidepressants; Pharmaceutical preparations for use in urology; Pharmaceutical products and preparations for treating chloasma; Pharmaceutical preparations for treating diabetes; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical solutions used in dialysis; Pharmaceutical products for ophthalmological use; Anti-epileptic pharmaceutical preparations; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating hypertension; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations for use in chemotherapy; anticoagulants; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating halitosis; Effervescent analgesic pharmaceutical preparations; Pharmaceutical preparations for the prevention of osteoporosis; Pharmaceutical preparations for treating asthma; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Analgesic and muscle relaxant pharmaceutical preparations; appetite suppressants; Pharmaceutical preparations for the treatment of dermatological disorders, namely, dermatitis, skin and bacterial skin infections and fungal skin infections; Pharmaceutical preparations for the treatment of dermatological disorders, namely, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema, and sexually transmitted diseases; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical preparations for treating chemical imbalances, namely, melancholia; Pharmaceutical preparations for reducing sexual activity; pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections; Pharmaceutical agents affecting digestive organs, namely, antiemetics; Pharmaceutical agents affecting digestive organs, namely, antacids; Pharmaceutical agents affecting digestive organs, namely, antidiarrheal medicines; Pharmaceutical agents affecting digestive organs, namely, medicines for alleviating constipation; Pharmaceutical agents affecting sensory organs, namely, eye drops; Pharmaceutical agents affecting sensory organs, namely, ear drops; Pharmaceutical agents affecting sensory organs, namely, nose drops; pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system namely brain, movement, ocular motility and spinal cord diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products for the treatment of joint disease; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of viral skin infections; pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); Pharmaceutical preparations for the relief of insect bites; Pharmaceutical preparations for the treatment of bone fractures; pharmaceutical hormonal preparations, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; Pharmaceutical preparations for treating allergic rhinitis; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical agents affecting peripheral nervous system, namely, anticonvulsants; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for treating asthma; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical preparations for the treatment of damaged skin and tissue, namely, bee stings, sunburn, rashes, sores, corns, calluses and acne; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; pharmaceutical preparations for the prevention of osteoporosis; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical products and preparations against dry skin caused by pregnancy; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical anti-viral agents; Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations for the treatment of sports injuries, namely, injured and torn muscle; Pharmaceutical preparations for knee cartilage regeneration; Pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory pelvic diseases; Pharmaceutical preparations and substances for the treatment of blood disorders, pain, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases, bacteria-based diseases and disorders, autoimmune diseases and disorders, kidney diseases and disorders, and diabetes; Antibiotics; antifungal preparations; human vaccines; Pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy and anemia; Pharmaceutical preparations for the treatment of metabolic disorders, namely, diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism; Pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely, growth and thyroid disorders, and neuromuscular diseases, namely, primary periodic paralysis; Pharmaceutical preparations for the treatment of endocrine diseases, namely, glucagonoma; Pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases and inflammatory pelvic diseases; Pharmaceutical preparations for the treatment of neurological diseases, namely, myasthenia gravis, Alzheimer's, Huntington's disease and cerebral palsy; Pharmaceutical preparations for the treatment of neurological disorders, namely, brain injury, spinal cord injury and seizure disorders; Pharmaceutical preparations and substances for the treatment of musculoskeletal, cardiopulmonary, oncological, hepatological, ophthalmic and gastrointestinal diseases and disorders; Pharmaceutical preparations and substances for the treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of disorders of the cardio-vascular system and the respiratory system; Pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders; Pharmaceutical preparations for use in hematology, namely, for the treatment of blood disorders; Pharmaceutical preparations for use in tissue and organ transplantation; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for the treatment of gastroenterological disorders.

Classification kind code

12

Class [040]
Custom manufacture of pharmaceuticals; Custom manufacturing of nutritional supplements.

Classification kind code

12

Mark Details

Serial Number

2059905

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 26
on 3rd Jun 2025		Approved
Submitted for opposition 27
on 3rd Jun 2025		Approval Notice Sent
Submitted for opposition 22
on 12th Jun 2024		Search Recorded
Submitted for opposition 20
on 12th Jun 2024		Examiner's First Report
Submitted for opposition 287
on 11th May 2022		Pre-Assessment Letter Sent
Submitted for opposition 30
on 26th Oct 2020		Filed
Submitted for opposition 1
on 26th Oct 2020		Created
Submitted for opposition 31
on 26th Oct 2020		Formalized